Krishnamurthy & Co (K Law) advised Biocon Biologics India when Tata Capital acquired a 0.85% stake in it for ₹2.25 billion (US$30 million). Platinum Partners advised Tata Capital, which invested through Tata Capital Growth Fund II.
Biocon Biologics India is a subsidiary of Biocon, a listed biopharmaceuticals company.
In a celebration of hard work, ingenuity and excellence, India Business Law Journal reveals the winners of the 2022 Indian Law Firm Awards
Preparing for India’s multi-agency dawn raids: Building response architecture, preserving privilege and documenting every step
Life insurers’ digital shift demands stronger legal oversight to protect customer data and cyber resilience
Shared venture documentation gaps slow India funding rounds and shape foreign capital perceptions of ecosystem maturity
To what extent does party autonomy hold sway over contracts that involve exceptional or prohibited clauses?
